Effect of folate treatment on homocysteinemia in cardiac patients: A prospective study

Indian Journal of Pharmacology

Volumn 37, Issue 1, 2005, Pages 13-17

  Mehta, K N ^a   Chag, M C ^b   Parikh, K H ^b   Shah, U G ^b   Baxi, H A ^b   Chandarana, A H ^b   Naik, A M ^b   Goyal, Ramesh K ^a  

^a L M COLLEGE OF PHARMACY   (India)

^b Sterling Hospital   (India)

Author keywords

Coronary artery disease; Diabetes mellitus; Folic acid

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PROSPECTIVE STUDY; PROTEIN ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREADMILL ERGOMETRY;

EID: 13744259246     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.13848     Document Type: Article

References (30)

1. Enas EA, Mehta JL. Malignant Coronary Artery Disease in young Asian Indians. Thoughts on Pathogenesis, prevention and therapy. N Engl J Med 1995;333:1301-7.
2. Sethi KK. Homocysteine: An Easily Reversible Risk Factor for A-Atherosclerosis. Quartely J Cardiol 2002;1:7A-11A.
3. Bulatao RA, Stephens PW. Global estimates and projections of mortality by cause. Washington, DC: Population, Health and Nutrition Department World bank, Preworking paper; 1992.
4. Krishnaswami S, Prasad NK, Jose VJ. A study of lipid levels in Indian patients with coronary artery disease. Int J Cardiol 1989;24:337-45.
5. Hughes LO. Insulin, Indian origin and ischemie heart disease. Int J Cardiol 1990;26:1-4.
6. Vardan S, Mukherjee S, Vardan S, Sinha AKN. Special features of coronary heart disease in people of Indian subcontinent. Indian Heart J 1995;47:399-407.
7. Mehta J, Mehta P, Lowsen D, Salden T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 1987;9:263-8.
8. Kannel WB. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol 1995;76:69-77.
9. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55.
10. Perry IJ, Refsum H, Moris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-8.
11. Boushey CJ, Beresford SAA, Omenn GS, Motusky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995;247:1049-57.
12. Ubbink JB, Becker PJ, Vermaak WJ, Delport R. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem 1995;41:1033-7.
13. McCully KS. Vascular pathology of homocysteinemia, implications for pathogenesis of artheriosclerosis. Am J Pathol 1969;56:111-28.
14. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 1994;91:6369-73.
15. Woo KS, Chook P, Lolin YI, Cheung AS, Chan LT, Sun YY, et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997;96:2542-4.
16. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996;348:1120-4.
17. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: The Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279-84.
18. Chambers JC, Obeid OA, Refsum H, Ueland P, Hackett D, Hooper J, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000;355:523-7.
19. Deepa R, Velmurugan K, Saravanan G, Karkuzhali K, Dwarakanath V, Mohan V. Absence of association between serum homocysteine levels and coronary artery disease in South Indian males. Indian Heart J 2001;53:44-7.
20. Gupta MD, Girish MP, Nigam A, Roy TNS, Sharma A, Tyagi S, et al. Hyperhomocysteinemia as a Risk Factor for Angiographic Coronary Artery Disease: Observations from a North Indian Community. Indian Heart J 2003;55:229.
21. Audelin MC, Genest J. Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis 2001;159:497-511.
22. Genest J Jr, Audelin MC, Lonn E. Homocysteine: To screen and treat or to wait and see? Can Med Assoc J 2001;163:37-8.
23. Nygard O, Refsum H, Ueland PM, Vollest SE. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. Am J Clin Nutr 1998;67:263-70.
24. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive Protein and its relation to cardiovascular risk factor: A population based cross sectional study. Br Med J 1996;312:1061-5.
25. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134-46.
26. Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus. Effect of parental methylcobalamin treatment. Atherosclerosis 1993;103:149-57.
27. Chambers JC, Obeid O, McGregor A, Powell-Tuck J, Boustead L, Kooner JS. The relationship between hyperhomocysteinemia and endothelial dysfunction is concentration-dependent and present even at physiological levels. Circulation 1998;98:1-192.
28. Langman LJ, Cole EC. Homocysteine: Cholesterol of the 90s? Clin Chim Acta 1999;286:63-80.
29. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
30. Woo K, Chook P, Lonin Y, Sanderson JE, Metreweli C, Celermajer OS. Folic acid improves arterial endothelial function in adults with hyperhomocysteinemia. J Am Coll Cardiol 1999;34:2002-6.